Header Logo

Connection

JORGE E CORTES to Oligonucleotides

Back to Details
This is a "connection" page, showing publications JORGE E CORTES has written about Oligonucleotides.
JORGE E CORTES
Connection Strength
0.355
Oligonucleotides
  1. Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia. Cancer. 2012 Jan 15; 118(2):418-27.
    View in: PubMed
    Score: 0.355
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.